PDS Biotechnology: Precision Designed Science Transforming How the Immune System Targets and Fights Cancer

With head and neck cancers on the rise, PDS Biotechnology is advancing an innovative pipeline of immunotherapies designed to harness the body's own immune system to attack cancer.

Health & Wellness
December 9, 2025
Request Investor InfoRequest Investor Info
PDS Biotechnology: Immunotherapy Reimagined for Head and Neck Cancer

‍

To learn more about PDS Biotechnology (Nasdaq: PDSB), please click the request investor info button.

‍

No items found.

You might also like

Lexaria Bioscience: Advancing Next-Generation Oral Weight-Loss Drugs
Life Sciences
August 28, 2026

Lexaria Bioscience: Advancing Next-Generation Oral Weight-Loss Drugs

Next-generation weight-management drugs face a simple challenge: effectiveness must be matched by tolerability.

This is some text inside of a div block.
Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?
Finance
August 27, 2026

Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?

This is some text inside of a div block.
Brompton Funds
ETFs
August 27, 2026

Brompton Funds: Enhanced Multi-Asset Income ETF - BMAX

BMAX is designed to provide attractive monthly distributions and the opportunity for capital appreciation by investing in a portfolio of Brompton ETFs and preferred shares.

This is some text inside of a div block.
Subscribe and receive the investor Info